Provisional
These webtables contain summarised cancer information detailing numbers of new primary malignant cancer registrations and the age-standardised registration rates for selected sites by year. The information is sourced from the New Zealand Cancer Registry, and is broken down by age, sex and ethnic group. The data is provisional only and is subject to change.
The cancers detailed are those given priority when information is reported to the New Zealand Cancer Registry. Data relating to these specific cancers is therefore available to be released (in a provisional form), earlier than the complete dataset. The cancers detailed in this report are:
| Cancer (ICD Code) | Sex | 2011 | 2012* | 2013* | |||
|---|---|---|---|---|---|---|---|
| Number | ASR | Number | ASR | Number | ASR | ||
| Cervix (C53) | Female | 165 | 6.6 | 166 | 6.3 | 164 | 6.4 |
| Colorectum and anus (C18–C21) | Total | 3030 | 44.2 | 3023 | 43.3 | 3066 | 42.6 |
| Male | 1635 | 52.0 | 1574 | 48.8 | 1624 | 48.6 | |
| Female | 1395 | 37.3 | 1449 | 38.4 | 1442 | 37.3 | |
| Female Breast (C50) | Female | 2867 | 92.5 | 3019 | 96.9 | 3007 | 94.4 |
| Leukaemia (C91–C95) | Total | 563 | 9.5 | 597 | 9.8 | 638 | 10.2 |
| Male | 328 | 11.6 | 355 | 12.3 | 391 | 13.3 | |
| Female | 235 | 7.7 | 242 | 7.7 | 247 | 7.5 | |
| Melanoma (C43) | Total | 2204 | 36.1 | 2325 | 36.7 | 2359 | 37.0 |
| Male | 1199 | 40.1 | 1230 | 40.2 | 1221 | 38.8 | |
| Female | 1005 | 33.0 | 1095 | 33.7 | 1138 | 35.7 | |
| Prostate (C61) | Male | 3023 | 97.4 | 3125 | 97.6 | 3136 | 95.1 |
| Lung (C33–C34) | Total | 2016 | 29.8 | 2026 | 29.2 | 1984 | 27.8 |
| Male | 1046 | 32.8 | 1060 | 32.2 | 1002 | 29.5 | |
| Female | 970 | 27.5 | 966 | 26.7 | 982 | 26.6 | |
| Hodgkin Lymphoma (C81) | Total | 100 | 2.1 | 91 | 1.8 | 116 | 2.5 |
| Male | 59 | 2.5 | 49 | 2.0 | 65 | 2.8 | |
| Female | 41 | 1.7 | 42 | 1.7 | 51 | 2.2 | |
| Non-Hodgkin Lymphoma (C82–C85,C96) | Total | 729 | 11.6 | 742 | 11.5 | 782 | 11.6 |
| Male | 379 | 12.9 | 432 | 13.9 | 458 | 14.5 | |
| Female | 350 | 10.5 | 310 | 9.3 | 324 | 9.1 | |
| Chronic myoproliferative disorders and myelodysplastic syndromes (D45–D47) | Total | 316 | 4.3 | 307 | 4.2 | 284 | 3.8 |
| Male | 194 | 5.9 | 177 | 5.3 | 175 | 5.0 | |
| Female | 122 | 3.1 | 130 | 3.2 | 109 | 2.8 | |
*2012 and 2013 cancer data is provisional and subject to change.
Source: New Zealand Cancer Registry
Note: ASR is the age-standardised rate per 100,000 population, standardised to the WHO world standard population.